[go: up one dir, main page]

ZA955781B - New chemical compound the preparation thereof and its use in pharmaceutical compositions - Google Patents

New chemical compound the preparation thereof and its use in pharmaceutical compositions

Info

Publication number
ZA955781B
ZA955781B ZA955781A ZA955781A ZA955781B ZA 955781 B ZA955781 B ZA 955781B ZA 955781 A ZA955781 A ZA 955781A ZA 955781 A ZA955781 A ZA 955781A ZA 955781 B ZA955781 B ZA 955781B
Authority
ZA
South Africa
Prior art keywords
preparation
pharmaceutical compositions
chemical compound
new chemical
new
Prior art date
Application number
ZA955781A
Other languages
English (en)
Inventor
Ralf Anderskewitz
Kurt Schromm
Ernst-Otto Renth
Franz Birke
Armin Fuegner
Hubert Heuer
Christopher Meade
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of ZA955781B publication Critical patent/ZA955781B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA955781A 1994-07-13 1995-07-12 New chemical compound the preparation thereof and its use in pharmaceutical compositions ZA955781B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4424714A DE4424714A1 (de) 1994-07-13 1994-07-13 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff

Publications (1)

Publication Number Publication Date
ZA955781B true ZA955781B (en) 1996-02-22

Family

ID=6523048

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955781A ZA955781B (en) 1994-07-13 1995-07-12 New chemical compound the preparation thereof and its use in pharmaceutical compositions

Country Status (25)

Country Link
US (1) US5686496A (fr)
EP (1) EP0770058A1 (fr)
JP (1) JPH10502646A (fr)
KR (1) KR970704674A (fr)
CN (1) CN1152303A (fr)
AU (1) AU2736895A (fr)
BG (1) BG101104A (fr)
BR (1) BR9508395A (fr)
CA (1) CA2194886A1 (fr)
CO (1) CO4410185A1 (fr)
CZ (1) CZ8297A3 (fr)
DE (1) DE4424714A1 (fr)
EE (1) EE9700065A (fr)
FI (1) FI970095L (fr)
HR (1) HRP950363A2 (fr)
HU (1) HUT76827A (fr)
IL (1) IL114572A0 (fr)
MX (1) MX9700245A (fr)
NO (1) NO970123L (fr)
PE (1) PE35196A1 (fr)
PL (1) PL318114A1 (fr)
SK (1) SK1897A3 (fr)
WO (1) WO1996002496A1 (fr)
YU (1) YU45395A (fr)
ZA (1) ZA955781B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486181B1 (en) 1992-08-28 2002-11-26 City Of Hope Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
US6191169B1 (en) 1992-08-28 2001-02-20 City Of Hope Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
AU5857296A (en) * 1995-05-17 1996-11-29 Eli Lilly And Company Use of leukotriene antagonists for alzheimer's disease
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19718334A1 (de) * 1997-04-30 1998-11-05 Boehringer Ingelheim Pharma Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ID24720A (id) 1997-12-12 2000-08-03 Novartis Ag Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6528491B2 (en) * 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
CA2433451A1 (fr) * 2001-01-16 2002-07-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Utilisation d'un antagoniste de ltb4 dans le traitement et/ou la prevention de maladies causees par une expression augmentee des genes de mucine
EP1420773A1 (fr) * 2001-08-31 2004-05-26 Neurochem (International) Limited Derives d'amidine destines au traitement de l'amylose
WO2004099783A2 (fr) * 2003-05-06 2004-11-18 Bayer Healthcare Ag Diagnostics et therapies destines a des maladies associees au recepteur ltb4 (ltb4) couple a la proteine g
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
BRPI0513046A (pt) * 2004-07-05 2008-04-22 Dong Wha Pharm Ind Co Ltd composição para prevenção e tratamento de doença inflamatória alérgica
DE602005023797D1 (de) * 2004-07-14 2010-11-04 Inflammation Res Ct Co Ltd Verfahren zur Hemmung von Tumormetastasierung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
NZ246593A (en) * 1992-02-05 1997-07-27 Boehringer Ingelheim Int Amidine derivatives; their preparation and medicaments containing them

Also Published As

Publication number Publication date
CO4410185A1 (es) 1997-01-09
JPH10502646A (ja) 1998-03-10
IL114572A0 (en) 1995-11-27
US5686496A (en) 1997-11-11
PE35196A1 (es) 1996-09-05
DE4424714A1 (de) 1996-01-18
FI970095A0 (fi) 1997-01-10
EE9700065A (et) 1997-08-15
EP0770058A1 (fr) 1997-05-02
NO970123D0 (no) 1997-01-10
CN1152303A (zh) 1997-06-18
CA2194886A1 (fr) 1996-02-01
HU9700060D0 (en) 1997-02-28
MX9700245A (es) 1997-05-31
WO1996002496A1 (fr) 1996-02-01
FI970095A7 (fi) 1997-01-10
FI970095L (fi) 1997-01-10
AU2736895A (en) 1996-02-16
CZ8297A3 (en) 1997-09-17
YU45395A (sh) 1997-12-05
SK1897A3 (en) 1997-08-06
BR9508395A (pt) 1997-12-23
PL318114A1 (en) 1997-05-12
HUT76827A (en) 1997-11-28
BG101104A (en) 1998-04-30
KR970704674A (ko) 1997-09-06
NO970123L (no) 1997-01-10
HRP950363A2 (en) 1997-08-31

Similar Documents

Publication Publication Date Title
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
IL116154A0 (en) Perhydroisoindole derivatives their preparation and pharmaceutical compositions containing the same
HUP9800792A3 (en) Benzylpiperidines and piperazines, their use and pharmaceutical compositions containing the same
IL115039A (en) Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL115483A0 (en) Urea derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL113389A0 (en) 1,4-Benzodiazepine compounds, pharmaceutical compositions containing them, their preparation and use
IL135646A0 (en) α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
IL135366A0 (en) Substituted benzoxazoles and pharmaceutical compositions containing the same
ZA955781B (en) New chemical compound the preparation thereof and its use in pharmaceutical compositions
HUP0100102A3 (en) Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
HUP0104852A3 (en) Oktahydro-pyrido-pyrazine derivatives and pharmaceutical compositions containing the same and their use
HUP0101733A3 (en) Pharmaceutical compositions containing sulfonyl-dipeptides and their use
IL116101A0 (en) Benzamide its preparation and pharmaceutical compositions containing it
IL125284A0 (en) Cephem compounds pharmaceutical compositions containing the same and use thereof
IL115272A0 (en) Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof
IL136045A0 (en) Pyridylpyrrole derivatives and pharmaceutical compositions containing the same
IL116279A0 (en) Cephem compounds and pharmaceutical compositions containing the same
ZA989238B (en) Benzimidazole compounds pharmaceutical compositions containing the compounds and their use
IL113916A0 (en) Carbamoylcarbohydrazides their preparation compositions containing them and their use
IL105349A0 (en) Pharmaceutical compositions containing beta-carbolines,methods for the preparation thereof and compounds for use in the preparation thereof
IL113415A0 (en) Dihydrodibenzoquinolinediones their preparation and use and pharmaceutical compositions containing them
IL115982A0 (en) Cyclolignan derivatives and pharmaceutical compositions containing the same